Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
When asked about the most useful knowledge or skill(s) gained, pharmacists cited the Fracture Risk Scale (n = 8), evidence for monitoring and supplementing vitamin D (n = 5), when to commence antiresorptive medication (n = 4), evidence for calcium supplements (n = 3), increased knowledge of osteoporosis and the importance of treatment (n = 3), and the potential for clinical diagnosis based on minimal trauma fractures (without the need for DEXA) (n = 2).
Source: Questionnaire. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Equipping pharmacists to improve osteoporosis management for aged care residents: a pilot study
Study design awaiting verification · Journal of Pharmaceutical Policy and Practice · 2026
Original publication title
Equipping pharmacists to improve osteoporosis management for aged care residents: a pilot study
© 2026 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Osteoporosis is a common yet poorly managed condition among aged care residents. This suboptimal management results from medication-related issues, including undertreatment, inappropriate medication choice, and inadequate monitoring. Pharmacists working in aged-care settings have expressed a desire to improve osteoporosis management. However, gaps in their knowledge about osteoporosis management for aged care residents hinder their ability to do so. Providing pharmacists with education on best practices for osteoporosis management could help address this gap. This study pilots an osteoporosis management education initiative for aged care pharmacists and assesses its acceptance and impact on clinical practice.
Source: BackgroundAbstract: What methods does the paper describe?
An education initiative, based on Australian clinical guidelines and consensus recommendations for osteoporosis management of aged care residents, was developed and delivered to pharmacists. The pharmacist's acceptance of the initiative and its impact on clinical practice were evaluated through a questionnaire, focus groups, and content analysis of medication review reports completed pre: and post-attending the education initiative.
Source: MethodsAbstract: Results
The education initiative was delivered to 33 pharmacists, and the content of 1030 medication reviews (515 pre: and 515 post-) was examined. The education initiative was positively received by pharmacists and found to improve their knowledge of osteoporosis. A statistically significant increase in the number of residents for whom medication-related problems relating to osteoporosis management was identified (χ2(1,1030) = 13.476, p < .001) was observed following the education initiative. However, Pharmaceutical Benefits Scheme criteria, a desire to avoid polypharmacy and lack of interprofessional collaboration, were found to be barriers to these medication-related problems being resolved.
Source: ResultsAbstract: Conclusion
The education initiative showed an increase in pharmacists’ knowledge and prioritisation of osteoporosis management for aged care residents. Barriers to these improvements in residents’ osteoporosis care were identified. Addressing these barriers is essential if pharmacists’ potential to enhance osteoporosis management in aged care residents is to be realised.
Source: ConclusionAuthors’ abstract
ABSTRACT
Background
Osteoporosis is a common yet poorly managed condition among aged care residents. This suboptimal management results from medication-related issues, including undertreatment, inappropriate medication choice, and inadequate monitoring. Pharmacists working in aged-care settings have expressed a desire to improve osteoporosis management. However, gaps in their knowledge about osteoporosis management for aged care residents hinder their ability to do so. Providing pharmacists with education on best practices for osteoporosis management could help address this gap. This study pilots an osteoporosis management education initiative for aged care pharmacists and assesses its acceptance and impact on clinical practice.
Methods
An education initiative, based on Australian clinical guidelines and consensus recommendations for osteoporosis management of aged care residents, was developed and delivered to pharmacists. The pharmacist's acceptance of the initiative and its impact on clinical practice were evaluated through a questionnaire, focus groups, and content analysis of medication review reports completed pre: and post-attending the education initiative.
Results
The education initiative was delivered to 33 pharmacists, and the content of 1030 medication reviews (515 pre: and 515 post-) was examined. The education initiative was positively received by pharmacists and found to improve their knowledge of osteoporosis. A statistically significant increase in the number of residents for whom medication-related problems relating to osteoporosis management was identified (χ2(1,1030) = 13.476, p < .001) was observed following the education initiative. However, Pharmaceutical Benefits Scheme criteria, a desire to avoid polypharmacy and lack of interprofessional collaboration, were found to be barriers to these medication-related problems being resolved.
Conclusion
The education initiative showed an increase in pharmacists’ knowledge and prioritisation of osteoporosis management for aged care residents. Barriers to these improvements in residents’ osteoporosis care were identified. Addressing these barriers is essential if pharmacists’ potential to enhance osteoporosis management in aged care residents is to be realised.
Publication and source details
Original title: Equipping pharmacists to improve osteoporosis management for aged care residents: a pilot study
Catherine Laird; Kylie A. Williams; Helen Benson
Journal of Pharmaceutical Policy and Practice · 2026
CONTACT Catherine Laird catherine.d.laird@student.uts.edu.au Graduate School of Health, University of Technology Sydney, Sydney, NSW 2007, Australia© 2026 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group2026The Author(s)https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T22:28:49.069073+00:00
DOI: 10.1080/20523211.2026.2669623 · PMC13195720